I agree that this site is using cookies. You can find further informations here.
X
Sellier-Leclerc, Anne-Laure
106  results:
Search for persons X
?
1

Anti-CFH-associated hemolytic uremic syndrome: do we still ..:

Ferri, Marion ; Zotta, Federica ; Donadelli, Roberta...
Pediatric Nephrology.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

Nedosiran Safety and Efficacy in PH1: Interim Analysis of P..:

Groothoff, Jaap ; Sellier-Leclerc, Anne-Laure ; Deesker, Lisa...
Kidney International Reports.  9 (2024)  5 - p. 1387-1396 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Efficacy and Safety of Lumasiran in Patients With Primary H..:

Saland, Jeffrey M. ; Lieske, John C. ; Groothoff, Jaap W....
Kidney International Reports.  9 (2024)  7 - p. 2037-2046 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Nephrocalcinosis can disappear in infants receiving early l..:

Kayal, Dima ; Sellier-Leclerc, Anne-Laure ; Acquaviva-Bourdain, Cécile...
Pediatric Nephrology.  39 (2024)  7 - p. 2079-2082 , 2024
Link: https://doi.org/10.1007/..
 
?
5

Metabolic Acidosis Is Associated With an Accelerated Declin..:

Prytula, Agnieszka ; Shroff, Rukshana ; van Gremberghe, Ineke...
Kidney International Reports.  9 (2024)  6 - p. 1684-1693 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Valganciclovir is not associated with decreased EBV infecti..:

Cheyssac, Elodie ; Savadogo, Hamidou ; Lagoutte, Nathan...
Frontiers in Pediatrics.  10 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
7

Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase ..:

Michael, Mini ; Groothoff, Jaap W. ; Shasha-Lavsky, Hadas...
American Journal of Kidney Diseases.  81 (2023)  2 - p. 145-155.e1 , 2023
Link: https://doi.org/10.1053/..
 
?
8

Validation of a prediction system for risk of kidney allogr..:

Hogan, Julien ; Divard, Gillian ; Aubert, Olivier...
American Journal of Transplantation.  23 (2023)  10 - p. 1561-1569 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Isolated kidney transplantation under lumasiran therapy in ..:

Sellier-Leclerc, Anne-Laure ; Metry, Elisabeth ; Clave, Stéphanie...
Nephrology Dialysis Transplantation.  38 (2022)  2 - p. 517-521 , 2022
Link: https://doi.org/10.1093/..
 
?
10

Idiopathic nephrotic syndrome relapse following COVID-19 va..:

Hummel, Aurélie ; Oniszczuk, Julie ; Kervella, Delphine...
Clinical Kidney Journal.  15 (2022)  8 - p. 1574-1582 , 2022
Link: https://doi.org/10.1093/..
 
?
11

Efficacy and safety of lumasiran for infants and young chil..:

Hayes, Wesley ; Sas, David J. ; Magen, Daniella...
Pediatric Nephrology.  38 (2022)  4 - p. 1075-1086 , 2022
Link: https://doi.org/10.1007/..
 
?
12

FC070: Lumasiran for Patients with Primary Hyperoxaluria Ty..:

Groothoff, Jaap ; Michael, Mini ; Shasha-Lavsky, Hadas...
Nephrology Dialysis Transplantation.  37 (2022)  Supplement_3 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
13

The effect of lumasiran therapy for primary hyperoxaluria t..:

Méaux, Marie-Noëlle ; Sellier-Leclerc, Anne-Laure ; Acquaviva-Bourdain, Cécile...
Pediatric Nephrology.  37 (2022)  4 - p. 907-911 , 2022
Link: https://doi.org/10.1007/..
 
?
14

Cardiac involvement in pediatric hemolytic uremic syndrome:

Tanné, Corentin ; Javouhey, Etienne ; Boyer, Olivia...
Pediatric Nephrology.  37 (2022)  12 - p. 3215-3221 , 2022
Link: https://doi.org/10.1007/..
 
?
15

Phase 3 trial of lumasiran for primary hyperoxaluria type 1..:

Sas, David J. ; Magen, Daniella ; Hayes, Wesley...
Genetics in Medicine.  24 (2022)  3 - p. 654-662 , 2022
Link: https://doi.org/10.1016/..
 
1-15